Active
Will drugs based on "tobacco" psychedelics be available by the end of 2026?
Volume~$293
YES chance
100 BPCX
100 BPCX
DescriptionScientists have created genetically modified tobacco that produces five types of psychoactive substances for medical purposes. In 2026, the focus is expected to shift from laboratory testing to efforts to standardize this method for pharmaceutical use. Given the strict regulations governing the distribution of such substances in the CIS and around the world, official recognition of tobacco as a “medicinal raw material” will require approval from the WHO or national regulators. Will the pharmaceutical industry be able to announce the first phase of clinical trials for drugs created specifically at this “plant factory”?
ConditionsYes: if, on or before December 31, 2026, any major pharmaceutical company or research institute officially announces the start of clinical trials for a drug whose active ingredient was derived from bioengineered tobacco.
No: if, by the end of 2026, the technology remains exclusively within the realm of academic research without progressing to the pharmaceutical manufacturing stage.
Timeline
OpenedApr 6, 2026, 8:16 PM
Closes
Aug 31, 2026, 8:59 PMChecking results
—EndsJan 7, 2027, 8:59 PM
OpenedApr 6, 2026, 8:16 PM
Closes
Aug 31, 2026, 8:59 PMChecking results
—EndsJan 7, 2027, 8:59 PM
ActivityView all
Top poll holdersView all
Voted for YES
#
User
Vol.
1
heySI1
heySI129 BPCX
2
joS_edge
joS_edge29 BPCX
3
NastyAeolis
NastyAeolis24 BPCX
4
InsaneHammock
InsaneHammock19 BPCX
5
111
11117 BPCX
Voted for NO
#
User
Vol.
1
ton_explore
ton_explore25 BPCX
2
ConicMalraux
ConicMalraux25 BPCX
3
FirmGang
FirmGang21 BPCX
4
MMTrader
MMTrader16 BPCX
5
buba
buba15 BPCX
Active
Will drugs based on "tobacco" psychedelics be available by the end of 2026?
Volume~$293
DescriptionScientists have created genetically modified tobacco that produces five types of psychoactive substances for medical purposes. In 2026, the focus is expected to shift from laboratory testing to efforts to standardize this method for pharmaceutical use. Given the strict regulations governing the distribution of such substances in the CIS and around the world, official recognition of tobacco as a “medicinal raw material” will require approval from the WHO or national regulators. Will the pharmaceutical industry be able to announce the first phase of clinical trials for drugs created specifically at this “plant factory”?
ConditionsYes: if, on or before December 31, 2026, any major pharmaceutical company or research institute officially announces the start of clinical trials for a drug whose active ingredient was derived from bioengineered tobacco.
No: if, by the end of 2026, the technology remains exclusively within the realm of academic research without progressing to the pharmaceutical manufacturing stage.